nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CHRM4—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0221	0.027	CbGpPWpGaD
Atropine—CHRM5—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0212	0.0259	CbGpPWpGaD
Atropine—Methylphenidate—SLC6A3—Gilles de la Tourette syndrome	0.021	0.301	CrCbGaD
Atropine—Dexmethylphenidate—SLC6A3—Gilles de la Tourette syndrome	0.021	0.301	CrCbGaD
Atropine—CHRM4—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0189	0.023	CbGpPWpGaD
Atropine—CHRM4—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0183	0.0224	CbGpPWpGaD
Atropine—CHRM5—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0181	0.0221	CbGpPWpGaD
Atropine—CHRM5—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0176	0.0214	CbGpPWpGaD
Atropine—CHRM4—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0171	0.0208	CbGpPWpGaD
Atropine—CHRM5—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0164	0.02	CbGpPWpGaD
Atropine—Cocaine—SLC6A3—Gilles de la Tourette syndrome	0.0159	0.228	CrCbGaD
Atropine—CHRM4—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0159	0.0194	CbGpPWpGaD
Atropine—CHRM4—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0154	0.0188	CbGpPWpGaD
Atropine—CHRM5—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0152	0.0186	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0149	0.0182	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0149	0.0182	CbGpPWpGaD
Atropine—CHRM5—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0148	0.018	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0147	0.018	CbGpPWpGaD
Atropine—CHRM4—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0144	0.0175	CbGpPWpGaD
Atropine—CHRM5—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0137	0.0168	CbGpPWpGaD
Atropine—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0127	0.0155	CbGpPWpGaD
Atropine—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0127	0.0155	CbGpPWpGaD
Atropine—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0126	0.0153	CbGpPWpGaD
Atropine—CHRM4—nervous system—Gilles de la Tourette syndrome	0.0125	0.113	CbGeAlD
Atropine—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0124	0.0151	CbGpPWpGaD
Atropine—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0123	0.015	CbGpPWpGaD
Atropine—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0122	0.0149	CbGpPWpGaD
Atropine—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.012	0.109	CbGeAlD
Atropine—CHRM4—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.012	0.0146	CbGpPWpGaD
Atropine—Benzatropine—SLC6A3—Gilles de la Tourette syndrome	0.0119	0.171	CrCbGaD
Atropine—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0115	0.0141	CbGpPWpGaD
Atropine—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0115	0.014	CbGpPWpGaD
Atropine—CHRM5—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0115	0.014	CbGpPWpGaD
Atropine—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0114	0.0139	CbGpPWpGaD
Atropine—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0107	0.0131	CbGpPWpGaD
Atropine—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0107	0.013	CbGpPWpGaD
Atropine—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0106	0.0129	CbGpPWpGaD
Atropine—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0104	0.0127	CbGpPWpGaD
Atropine—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0104	0.0126	CbGpPWpGaD
Atropine—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0103	0.0125	CbGpPWpGaD
Atropine—CHRM4—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0101	0.0123	CbGpPWpGaD
Atropine—CHRM5—nervous system—Gilles de la Tourette syndrome	0.00978	0.0884	CbGeAlD
Atropine—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00968	0.0118	CbGpPWpGaD
Atropine—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00965	0.0118	CbGpPWpGaD
Atropine—CHRM5—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00963	0.0118	CbGpPWpGaD
Atropine—CHRM4—brain—Gilles de la Tourette syndrome	0.00957	0.0864	CbGeAlD
Atropine—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00956	0.0117	CbGpPWpGaD
Atropine—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.00942	0.0851	CbGeAlD
Atropine—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00807	0.00984	CbGpPWpGaD
Atropine—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00804	0.00981	CbGpPWpGaD
Atropine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00796	0.00972	CbGpPWpGaD
Atropine—CHRM5—brain—Gilles de la Tourette syndrome	0.00748	0.0676	CbGeAlD
Atropine—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00678	0.00827	CbGpPWpGaD
Atropine—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00676	0.00825	CbGpPWpGaD
Atropine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.00671	0.0607	CbGeAlD
Atropine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00669	0.00817	CbGpPWpGaD
Atropine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00646	0.0584	CbGeAlD
Atropine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00611	0.0552	CbGeAlD
Atropine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.00588	0.0532	CbGeAlD
Atropine—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00564	0.00688	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00558	0.00681	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00547	0.00668	CbGpPWpGaD
Atropine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.00547	0.0494	CbGeAlD
Atropine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00542	0.00661	CbGpPWpGaD
Atropine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.00527	0.0476	CbGeAlD
Atropine—CHRM2—brain—Gilles de la Tourette syndrome	0.00513	0.0464	CbGeAlD
Atropine—CHRM1—brain—Gilles de la Tourette syndrome	0.00467	0.0422	CbGeAlD
Atropine—CHRM3—brain—Gilles de la Tourette syndrome	0.00418	0.0378	CbGeAlD
Atropine—CHRM4—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00393	0.00479	CbGpPWpGaD
Atropine—CHRM4—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00381	0.00465	CbGpPWpGaD
Atropine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00364	0.00445	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00357	0.00436	CbGpPWpGaD
Atropine—CHRM4—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00355	0.00433	CbGpPWpGaD
Atropine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00354	0.00432	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00354	0.00432	CbGpPWpGaD
Atropine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00349	0.00426	CbGpPWpGaD
Atropine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00339	0.00413	CbGpPWpGaD
Atropine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0033	0.00402	CbGpPWpGaD
Atropine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00316	0.00385	CbGpPWpGaD
Atropine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00312	0.00381	CbGpPWpGaD
Atropine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00303	0.0037	CbGpPWpGaD
Atropine—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.003	0.00366	CbGpPWpGaD
Atropine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00299	0.00365	CbGpPWpGaD
Atropine—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00291	0.00355	CbGpPWpGaD
Atropine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0029	0.00354	CbGpPWpGaD
Atropine—CHRM5—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00286	0.00349	CbGpPWpGaD
Atropine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00282	0.00345	CbGpPWpGaD
Atropine—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00271	0.00331	CbGpPWpGaD
Atropine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0027	0.0033	CbGpPWpGaD
Atropine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00261	0.00319	CbGpPWpGaD
Atropine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00256	0.00312	CbGpPWpGaD
Atropine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00254	0.0031	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00246	0.003	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00245	0.00299	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00243	0.00296	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00239	0.00291	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00238	0.0029	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00238	0.0029	CbGpPWpGaD
Atropine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00236	0.00288	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00236	0.00287	CbGpPWpGaD
Atropine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00231	0.00282	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00231	0.00282	CbGpPWpGaD
Atropine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.0023	0.0028	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00228	0.00278	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00222	0.00271	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00222	0.0027	CbGpPWpGaD
Atropine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00221	0.0027	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00221	0.0027	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00219	0.00268	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00215	0.00262	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00211	0.00257	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0021	0.00256	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00208	0.00254	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00206	0.00251	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00204	0.00249	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00204	0.00249	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00202	0.00246	CbGpPWpGaD
Atropine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00201	0.00246	CbGpPWpGaD
Atropine—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00201	0.00245	CbGpPWpGaD
Atropine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00198	0.00241	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0019	0.00232	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0019	0.00232	CbGpPWpGaD
Atropine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00189	0.00231	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00188	0.00229	CbGpPWpGaD
Atropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0018	0.0022	CbGpPWpGaD
Atropine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0018	0.00219	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0016	0.00196	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0016	0.00195	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00158	0.00193	CbGpPWpGaD
Atropine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00156	0.0019	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00156	0.0019	CbGpPWpGaD
Atropine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00155	0.00189	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00155	0.00189	CbGpPWpGaD
Atropine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00154	0.00187	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00154	0.00187	CbGpPWpGaD
Atropine—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00153	0.00187	CbGpPWpGaD
Atropine—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00151	0.00184	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00145	0.00177	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00145	0.00176	CbGpPWpGaD
Atropine—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00144	0.00176	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00143	0.00175	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00134	0.00164	CbGpPWpGaD
Atropine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00133	0.00163	CbGpPWpGaD
Atropine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00133	0.00162	CbGpPWpGaD
Atropine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00132	0.00161	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0013	0.00159	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00129	0.00157	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00125	0.00152	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00122	0.00149	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00122	0.00148	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00118	0.00145	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00117	0.00143	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00116	0.00142	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00113	0.00138	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.0011	0.00135	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00106	0.00129	CbGpPWpGaD
Atropine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00124	CbGpPWpGaD
Atropine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00101	0.00124	CbGpPWpGaD
Atropine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.001	0.00122	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000906	0.00111	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000903	0.0011	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000894	0.00109	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00088	0.00107	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000877	0.00107	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000868	0.00106	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000851	0.00104	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000823	0.001	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00082	0.001	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000819	0.001	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000817	0.000997	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000815	0.000995	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000812	0.000991	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000809	0.000987	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000799	0.000975	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000796	0.000972	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000789	0.000962	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000776	0.000947	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000773	0.000943	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000744	0.000908	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000742	0.000905	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00074	0.000903	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000735	0.000896	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000721	0.00088	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0007	0.000854	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00069	0.000842	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00067	0.000818	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000652	0.000795	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000624	0.000762	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000574	0.0007	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000572	0.000698	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000567	0.000691	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000521	0.000636	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00052	0.000634	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000514	0.000628	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000486	0.000593	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000485	0.000591	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00048	0.000585	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000472	0.000576	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00047	0.000574	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000466	0.000568	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000457	0.000557	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00044	0.000536	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000438	0.000535	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000437	0.000534	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000434	0.000529	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000308	0.000376	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000307	0.000374	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000304	0.000371	CbGpPWpGaD
